APC and colorectal cancer: In a majority of colorectal cancer cases, biallelic mutations of APC—which encodes a key component of the β-catenin destruction complex—lead to unmitigated stabilization of β-catenin (81), thereby driving constitutive pathway activation independent of Wnt ligands.